Rho(D) immune globulin (anti-D)

🧮 Dose calculator

Rh(D) isoimmunisation prophylaxis (Rh-negative mother) · Regimen source: FDA RhoGAM · 2.1

• • Pregnancy: 26–28 weeks. Postpartum (if newborn Rh-positive): within 72 h. Abortion, ectopic, invasive procedure or trauma after 13 weeks: within 72 h. Fetal-maternal haemorrhage >15 mL red cells: 20 mcg per mL of Rh-positive red cells, rounded up to the next whole syringe. FDA RhoGAM · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA RhoGAM · 1.1

  “RhoGAM is indicated for administration to Rh-negative women not previously sensitized to the Rho(D) factor, unless the father or baby are conclusively Rh-negative, in case of: Delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby Antepartum prophylaxis at 26 to 28 weeks gestation …”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA RhoGAM · 8.2

  “Risk Summary RhoGAM can be used during breastfeeding.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA RhoGAM · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA RhoGAM · 8.5

  “No clinical studies have been performed in geriatric subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.